It's How Medicine Should Be®

Font Size:

-A +A

Translate

French German Italian Portuguese Russian

Individuals Aged 70 or Over and Low-Dose Aspirin Use Study

Clinical Trial Title: 
Study of Low-Dose Aspirin Use in Healthy Individuals Aged 70 and Over
Clinical Trial Protocol ID: 
09121005
Clinical Trial Investigator Name: 
Raj Shah, MD
Clinical Trial Protocol Description: 

The purpose of this study is to determine whether aspirin can prolong disability-free life by preventing thinking problems (such as memory loss and dementia), heart disease, stroke, certain cancers, and physical disability (such as walking difficulties) in healthy people over the age of 70.

As a participant in this research study, you will be randomly assigned to take either aspirin or placebo (identical tablet without aspirin) once a day for about five years. You will be followed annually to monitor your blood pressure and cholesterol levels, physical abilities, and memory.

All study related-visits and medications are provided at not cost to you.

Approximately 19,000 individuals from across the United States and Australia are expected to take part in this study. We expect to enroll approximately 800 participants here at Rush University Medical Center.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are 70 years of age or older
  • Are in good health

You will be excluded from this study if you:

  • Are allergic to aspirin
  • Are currently taking aspirin at the instruction of your doctor

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Alzheimer’s Disease and Related Dementias
Contact Phone: 
(312) 942-6596
Contact Name: 
Scarlett Ellis